✦ LIBER ✦

Sequential Down Syndrome Screening: The Importance of First and Second Trimester Test Correlations when Calculating Risk

✍ Scribed by Peter Benn; Alan E. Donnenfeld

Book ID: 106413679
Publisher: Springer
Year: 2005
Tongue: English
Weight: 67 KB
Volume: 14
Category: Article
ISSN: 1059-7700
DOI: 10.1007/s10897-005-6390-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Screening for Down syndrome during the f

Screening for Down syndrome during the first and second trimesters: Impact of risk estimation parameters

✍ Jean-Claude Forest; Jacques Massé; François Rousseau; Jean-Marie Moutquin; Natal 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 790 KB

Women's opinions and the implications of

Women's opinions and the implications of first- versus second-trimester screening for fetal Down's syndrome

✍ L. H. Kornman; M. J. M. Wortelboer; J. R. Beekhuis; L. P. Morssink; A. Mantingh 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 3 views

Two groups of pregnant women were questioned regarding their opinions on serum screening for Down's syndrome in the first trimester of pregnancy. One group comprised 83 women attending our antenatal clinic who were questioned at the time of the existing second-trimester screening test. Seventy-six p

First-trimester screening for Down syndr

First-trimester screening for Down syndrome using nuchal translucency measurement with free β-hCG and PAPP-A between 10 and 13 weeks of pregnancy—the combined test

✍ P. De Biasio; M. Siccardi; G. Volpe; L. Famularo; F. Santi; S. Canini 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 3 views

In a population of 1467 women attending the 'G. Gaslini' Institute for antenatal care, we evaluated first-trimester risk screening for Down syndrome using the 'combined test' based on ultrasound measurement of nuchal translucency (NT), maternal serum pregnancy-associated plasma protein A (PAPP-A) an